Laura M. Rogers, Ph.D. - Publications

2012 Anatomy & Cell Biology University of Iowa, Iowa City, IA 
Cell Biology, Molecular Biology, Genetics

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Vianzon VV, Hanson RM, Garg I, Joseph GJ, Rogers LM. Rank aggregation of independent genetic screen results highlights new strategies for adoptive cellular transfer therapy of cancer. Frontiers in Immunology. 14: 1235131. PMID 38143765 DOI: 10.3389/fimmu.2023.1235131  0.335
2020 Rogers LM, Wang Z, Mott SL, Dupuy AJ, Weiner GJ. A genetic screen to identify gain- and loss-of-function modifications that enhance T-cell infiltration into tumors. Cancer Immunology Research. PMID 32611665 DOI: 10.1158/2326-6066.Cir-20-0056  0.66
2020 Rogers LM, Dupuy AJ, Weiner GJ. Abstract A51: Rationally improving T cell-mediated cancer immunotherapies using Sleeping Beauty mutagenesis to identify novel therapeutic targets Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm18-A51  0.664
2016 Sun Z, Yu W, Navarro MS, Sweat M, Eliason S, Sharp T, Liu H, Seidel K, Zhang L, Moreno M, Lynch T, Holton NE, Rogers L, Neff T, Goodheart MJ, et al. Sox2 and Lef-1 interact with Pitx2 to regulate incisor development and stem cell renewal. Development (Cambridge, England). PMID 27660324 DOI: 10.1242/Dev.138883  0.577
2016 Rogers LM, Dupuy AJ, Weiner GJ. Abstract 526: Identification of novel cancer immunotherapy targets using Sleeping Beauty mutagenesis Immunology. 76: 526-526. DOI: 10.1158/1538-7445.Am2016-526  0.655
2014 Riordan JD, Drury LJ, Smith RP, Brett BT, Rogers LM, Scheetz TE, Dupuy AJ. Sequencing methods and datasets to improve functional interpretation of sleeping beauty mutagenesis screens. Bmc Genomics. 15: 1150. PMID 25526783 DOI: 10.1186/1471-2164-15-1150  0.718
2014 Gibson-Corley KN, Rogers LM, Goeken A, Dupuy AJ, Meyerholz DK. Keratoacanthoma Pathobiology in Mouse Models. Diseases (Basel, Switzerland). 2: 106-119. PMID 25309748 DOI: 10.3390/Diseases2020106  0.633
2014 Rogers LM, Veeramani S, Weiner GJ. Complement in monoclonal antibody therapy of cancer. Immunologic Research. 59: 203-10. PMID 24906530 DOI: 10.1007/S12026-014-8542-Z  0.379
2013 Rogers LM, Olivier AK, Meyerholz DK, Dupuy AJ. Adaptive immunity does not strongly suppress spontaneous tumors in a Sleeping Beauty model of cancer. Journal of Immunology (Baltimore, Md. : 1950). 190: 4393-9. PMID 23475219 DOI: 10.4049/Jimmunol.1203227  0.67
2013 Rogers LM, Riordan JD, Swick BL, Meyerholz DK, Dupuy AJ. Ectopic expression of Zmiz1 induces cutaneous squamous cell malignancies in a mouse model of cancer. The Journal of Investigative Dermatology. 133: 1863-9. PMID 23426136 DOI: 10.1038/Jid.2013.77  0.715
2011 Nadkarni N, Rogers L, Samuelson M, Neff T, Bender D, Ahmed A, De Geest K, Button A, Dupuy A, Goodheart M. Zmiz1 is overexpressed in epithelial ovarian cancer and associated with p53 gene mutations Gynecologic Oncology. 123: 446-447. DOI: 10.1016/J.Ygyno.2011.07.084  0.658
2011 Riordan JD, Rogers LM, Berquam-Vrieze KE, Dupuy AJ. Sleeping beauty models of cancer Insertional Mutagenesis Strategies in Cancer Genetics. 113-130. DOI: 10.1007/978-1-4419-7656-7_5  0.706
2010 Rogers LM, Swick BL, Meyerholz DK, Dupuy AJ. Abstract 249: A Sleeping Beauty screen in mice identifies Zmiz1 as a candidate cancer gene in human squamous cell carcinomas Cellular and Molecular Biology. 70: 249-249. DOI: 10.1158/1538-7445.Am10-249  0.679
2009 Dupuy AJ, Rogers LM, Kim J, Nannapaneni K, Starr TK, Liu P, Largaespada DA, Scheetz TE, Jenkins NA, Copeland NG. A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice. Cancer Research. 69: 8150-6. PMID 19808965 DOI: 10.1158/0008-5472.Can-09-1135  0.713
2005 Downs LS, Rogers LM, Yokoyama Y, Ramakrishnan S. Thalidomide and angiostatin inhibit tumor growth in a murine xenograft model of human cervical cancer. Gynecologic Oncology. 98: 203-10. PMID 15975645 DOI: 10.1016/j.ygyno.2005.04.023  0.336
Show low-probability matches.